Actionable news
0
All posts from Actionable news
Actionable news in ADAP: Adaptimmune Therapeutics PLC,

Adaptimmune Therapeutics PLC ADR

Average Recommendation: Buy Average Target Price: 18.60
Number of Ratings: 5 Current Quarters Estimate: -0.13
FY Report Date: 12 / 2016 Current Year's Estimate: -0.37
Last Quarter's Earnings: N/A Median PE on CY...

More